» Articles » PMID: 36685148

Knowledge, Perception and Acceptance of Generic Drugs in the General Lebanese Population: A Cross-sectional Survey Among Adults

Overview
Journal J Med Access
Date 2023 Jan 23
PMID 36685148
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Many governments encouraged generic use to enhance health equality and minimise health expenditure. The lack of knowledge and acceptance of generic medicines are the main barriers to their use.

Objectives: This study aimed to assess population knowledge and perception towards generic drugs, identify their primary sources of information and examine which variables are independently related to their acceptance.

Design: An observational cross-sectional study was performed targeting the Lebanese adult population.

Methods: Overall, 385 patients participated in the study. Data were collected using a uniform survey from six public healthcare centres.

Results: The participants reported a distrust towards generic drugs; they either said that they were not as effective as the brand (36.9%), were of less quality than the brand (38.5%) or had more side effects than the brand (38.4%). Around 52% said they would never buy a generic drug, and two-thirds (68.6%) preferred using a brand drug over a generic one. After adjusting for socio-demographics, a high income (odds ratio (OR) = 3.7), knowing that brands and generics have the same active ingredients (OR = 2.28) and that brands and generics were equally effective (OR = 6.46) were the strongest independent predictors for the willingness to buy generic drugs.

Conclusion: A lack of knowledge and misperceptions about generic drugs limited the use of generic drugs, and therefore must be addressed.

Citing Articles

Evaluation of public's knowledge, attitude and experiences towards the generic medications in building healthcare policy.

Akhtar M, Orayj K PLoS One. 2024; 19(11):e0311627.

PMID: 39495802 PMC: 11534256. DOI: 10.1371/journal.pone.0311627.


Assessment of community pharmacists' knowledge of the differences between generic drugs and biosimilars: A pilot cross-sectional study.

Awada S, Sayah R, Mansour M, Nabhane C, Hatem G J Med Access. 2023; 7:27550834231167049.

PMID: 37091630 PMC: 10119850. DOI: 10.1177/27550834231167049.

References
1.
Marwitz K . The pharmacist's active role in combating COVID-19 medication misinformation. J Am Pharm Assoc (2003). 2020; 61(2):e71-e74. PMC: 7640945. DOI: 10.1016/j.japh.2020.10.022. View

2.
Quintal C, Mendes P . Underuse of generic medicines in Portugal: an empirical study on the perceptions and attitudes of patients and pharmacists. Health Policy. 2011; 104(1):61-8. DOI: 10.1016/j.healthpol.2011.10.001. View

3.
Kjoenniksen I, Lindbaek M, Granas A . Patients' attitudes towards and experiences of generic drug substitution in Norway. Pharm World Sci. 2006; 28(5):284-9. DOI: 10.1007/s11096-006-9043-5. View

4.
Khazzaka M . Pharmaceutical marketing strategies' influence on physicians' prescribing pattern in Lebanon: ethics, gifts, and samples. BMC Health Serv Res. 2019; 19(1):80. PMC: 6354386. DOI: 10.1186/s12913-019-3887-6. View

5.
Beran R . Generic Substitution and Advice to Patients -Potential Legal Medicine Consequences - From A (Australia) to U (United Kingdom or United States of America). Seizure. 2021; 91:515-519. DOI: 10.1016/j.seizure.2021.03.016. View